tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Lexicon Pharmaceuticals Reports Strong Q2 2025 Results
PremiumCompany AnnouncementsLexicon Pharmaceuticals Reports Strong Q2 2025 Results
1M ago
Lexicon Pharmaceuticals Reports Strong Q2 2025 Earnings
Premium
Company Announcements
Lexicon Pharmaceuticals Reports Strong Q2 2025 Earnings
1M ago
Lexicon Pharmaceuticals: Strategic R&D Advancements and Strong Financial Performance Justify Buy Rating
Premium
Ratings
Lexicon Pharmaceuticals: Strategic R&D Advancements and Strong Financial Performance Justify Buy Rating
1M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
2M ago
Lexicon Pharmaceuticals Granted Nasdaq Compliance Extension
Premium
Company Announcements
Lexicon Pharmaceuticals Granted Nasdaq Compliance Extension
2M ago
Promising Outlook for Lexicon Pharmaceuticals’ Sotagliflozin in Type 1 Diabetes Management
Premium
Ratings
Promising Outlook for Lexicon Pharmaceuticals’ Sotagliflozin in Type 1 Diabetes Management
2M ago
Lexicon Pharmaceuticals’ Earnings Call Highlights Strategic Gains
PremiumCompany AnnouncementsLexicon Pharmaceuticals’ Earnings Call Highlights Strategic Gains
4M ago
Lexicon Pharmaceuticals: Hold Rating Amid Strategic Restructuring and Clinical Uncertainties
Premium
Ratings
Lexicon Pharmaceuticals: Hold Rating Amid Strategic Restructuring and Clinical Uncertainties
4M ago
Lexicon Pharmaceuticals: Strong Financials and Promising R&D Pipeline Justify Buy Rating
Premium
Ratings
Lexicon Pharmaceuticals: Strong Financials and Promising R&D Pipeline Justify Buy Rating
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100